LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />
periodically. Organ weights and gross pathological findings were measured<br />
at the end of the study in the liver, kidneys, spleen, heart, adrenals, pituitary,<br />
and cecum.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: C10-13 <strong>LAS</strong>, sodium salt, activity: 39.5%; average molecular weight 346;<br />
average alkyl chain length = 11.9<br />
Reference: Oser, B.L. and Morgareidge, K. 1965. Toxicological studies with branched<br />
and linear alkyl benzene sulfonates in rats. Toxicol. Appl. Pharmacol. 7:819-<br />
825.<br />
Reliability: 2 Valid with restrictions<br />
(b)<br />
Species/strain: rat (Sprague-Dawley)<br />
Sex: Female [ ]; Male [ ]; Male/Female [X]; No data [ ]<br />
Administration: oral feed<br />
Exposure period: 90 days<br />
Frequency of treatment: Ad libitum<br />
Dose: 0.02/0.1/0.5% (corresponding to 8.8, 44 and 220 mg/kg bw d)<br />
Control group: Yes [X]; No [ ]; No data [ ];<br />
Concurrent no treatment [X]; Concurrent vehicle [ ]; Historical [ ]<br />
NOAEL: 0.5% (220 mg/kg bw d)<br />
Results: No adverse effects were found upon the following parameters: growth, food<br />
efficiency, survival, haematologic values, and urinary analytical values. In<br />
addition, no treatment-related adverse effects were observed in absolute and<br />
relative organ weights, nor were gross histopathological changes observed in<br />
any of the organs examined.<br />
Method: Groups of 10 male and 10 female weanling rats were fed levels of 0.02, 0.1<br />
or 0.5% <strong>LAS</strong> in a commercial chow for 90 days. Body weights, food<br />
consumption, mortality, and several blood parameters were measured<br />
periodically during the study and at termination. Autopsy and microscopic<br />
examination of the organs was performed at test termination. Organ weights<br />
and gross pathological findings were recorded for the liver, kidneys, spleen,<br />
gonads, heart, and brain.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: C10-14 <strong>LAS</strong>, sodium salt (CAS #69669-44-9), activity: 87.9%; C10 1.8%, C11<br />
43.2%, C12 32.2%, C13 16.0%, C14 5.3%, C15 1.5%; average alkyl chain<br />
length = C11.8; mean molecular weight 346.<br />
Remarks: Two male rats at the 0.2% level died in the early stages of the study. These<br />
deaths were attributed to respiratory illness and were not considered to be<br />
treatment related.<br />
Reference: Kay, J.H., Kohn, F.E. and Calandra, J.C. 1965. Subacute oral toxicity of a<br />
biodegradable linear alkylbenzene sulfonate. Toxicol. Appl. Pharmacol.<br />
7:812-818.<br />
Reliability: 2 Valid with restrictions<br />
(c)<br />
Species/strain: Rat/Sprague-Dawley<br />
Sex: Female [ ]; Male [ ]; Male/Female [X]; No data [ ]<br />
Administration: gavage<br />
Exposure period: one month<br />
Frequency of treatment: daily<br />
Dose: 125, 250, 500 mg/kg bw d.<br />
Control group: Yes [X]; No [ ]; No data [ ];<br />
Concurrent no treatment [X]; Concurrent vehicle [ ]; Historical [ ]<br />
NOAEL: 125 mg/kg bw d<br />
LOAEL: 250 mg/kg bw d<br />
<strong>UNEP</strong> PUBLICATIONS 271